In pancreatic cancer cell lines, irisin activated adenosine monophosphate-activated protein kinase, downregulated the mTOR pathway and inhibited epithelial-to-mesenchymal transition leading to the suppression of the cell growth [96]. The gene discussed is FNDC5; the disease is pancreatic neoplasm.